Drug intelligence / Profile preview

Liuzhenbao Gel

Development stage: Preclinical
Lead developer: Shanghai Leiyunshang Pharmaceutical
Administration: Topical

Overview

Liuzhenbao Gel (六珍宝凝胶) is a topical Traditional Chinese Medicine (TCM) formulation currently in development by Lei Yun Shang. It is part of the company's research and development pipeline, specifically within their Institute of Chinese Medicine. As a TCM product, it likely comprises a multi-ingredient herbal formulation, potentially based on the 'Liuzhen' (Six Treasures) traditional recipe which often includes precious materials used for anti-inflammatory or dermatological purposes. While specific molecular targets and clinical trial phases are not disclosed in standard Western pharmaceutical formats, the drug is designed for topical application to treat unspecified conditions, likely related to inflammation, pain, or skin health.

Brand names: Liuzhenbao Gel
Other names: 六珍宝凝胶Liuzhenbao Ningjiao

Beyond the preview

Go deeper on Liuzhenbao Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liuzhenbao Gel.

Explore the full profile